Mar 22 | Sep 21 | Mar 21 | Sep 20 | Mar 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | £ 197.20M | £ 43.40M | £ 108.80M | £ 100.50M | £ 172.20M |
Total Assets | £ 1.90B | £ 1.74B | £ 1.69B | £ 1.61B | £ 1.74B |
Total Debt | £ 257.50M | £ 75.20M | £ 72.20M | £ 33.20M | £ 330.10M |
Net Debt | £ 60.30M | £ 31.80M | £ -36.60M | £ -67.30M | £ 157.90M |
Total Liabilities | £ 992.20M | £ 631.80M | £ 571.40M | £ 523.80M | £ 847.70M |
Stockholders Equity | £ 906.00M | £ 1.11B | £ 1.12B | £ 1.09B | £ 887.10M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |